Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
GO_Biological_Process_2021,Hedgehog signaling pathway,6/56,6.612913618167685e-05,0.0125645358745186,0,0,9.769586776859503,94.02153711193812,CSNK1A1;SUFU;GPR161;CSNK1D;PRKACA;CSNK1G2
GO_Biological_Process_2021,Longevity regulating pathway,6/102,0.0017090484634592,0.1623596040286332,0,0,5.076446280991736,32.34619441612926,HDAC2;RHEB;CREB3L2;TSC2;PRKACA;SOD1
GO_Biological_Process_2021,mTOR signaling pathway,7/154,0.0031448334521313,0.1991727853016535,0,0,3.873740367516301,22.320470097937445,ATP6V1G1;SEC13;RHEB;TSC2;SLC38A9;ATP6V1E1;LPIN1
GO_Biological_Process_2021,Rheumatoid arthritis,5/93,0.0060397007797663,0.2868857870389031,0,0,4.597830153385709,23.49215710092273,ATP6V1G1;TGFB2;CSF1;CTSL;ATP6V1E1
GO_Biological_Process_2021,Amphetamine addiction,4/69,0.0106307453481942,0.4039683232313801,0,0,4.965195460277427,22.561872856786863,PPP1CC;HDAC2;CREB3L2;PRKACA
GO_Biological_Process_2021,Proteoglycans in cancer,7/205,0.0142533424377804,0.4455054468276267,0,0,2.868477304161952,12.19321960823602,VAV3;PPP1CC;TGFB2;CTSL;PDCD4;TWIST1;PRKACA
GO_Biological_Process_2021,Protein processing in endoplasmic reticulum,6/171,0.0200301224805881,0.4455054468276267,0,0,2.943200601051841,11.509438970600335,SEC13;SEC24A;SELENOS;OS9;HSPA4L;MARCHF6
GO_Biological_Process_2021,Human papillomavirus infection,9/331,0.0227995732341716,0.4455054468276267,0,0,2.272278385612932,8.59151516313369,ATP6V1G1;HDAC2;CSNK1A1;RHEB;CREB3L2;COL4A6;TSC2;ATP6V1E1;PRKACA
GO_Biological_Process_2021,Gap junction,4/88,0.0239331076392984,0.4455054468276267,0,0,3.838407494145199,14.3268272673392,GJA1;TUBA1A;CSNK1D;PRKACA
GO_Biological_Process_2021,Vibrio cholerae infection,3/50,0.0240708410298452,0.4455054468276267,0,0,5.133738601823708,19.13218131490227,ATP6V1G1;ATP6V1E1;PRKACA
GO_Biological_Process_2021,Autophagy,5/137,0.028137186115429,0.4455054468276267,0,0,3.058361391694725,10.920378559852155,RHEB;CTSL;TSC2;WIPI1;PRKACA
GO_Biological_Process_2021,Insulin signaling pathway,5/137,0.028137186115429,0.4455054468276267,0,0,3.058361391694725,10.920378559852155,PPP1CC;PTPN1;RHEB;TSC2;PRKACA
GO_Biological_Process_2021,Collecting duct acid secretion,2/27,0.0438628528459387,0.5627636623456402,0,0,6.415284552845528,20.05858998016962,ATP6V1G1;ATP6V1E1
GO_Biological_Process_2021,Cellular senescence,5/156,0.0451665227739878,0.5627636623456402,0,0,2.670945411931431,8.272983950192033,PPP1CC;TGFB2;RHEB;TSC2;ZFP36L2
GO_Biological_Process_2021,Long-term potentiation,3/67,0.0505571539994209,0.5627636623456402,0,0,3.766836734693877,11.242692350126193,RAP1B;PPP1CC;PRKACA
GO_Biological_Process_2021,Hippo signaling pathway,5/163,0.052706513761832,0.5627636623456402,0,0,2.5517007865812364,7.509696829724249,PPP1CC;TGFB2;WWC1;CSNK1D;NKD1
GO_Biological_Process_2021,cAMP signaling pathway,6/216,0.0528825841421582,0.5627636623456402,0,0,2.307201889020071,6.782438056030663,VAV3;RAP1B;PPP1CC;CREB3L2;PDE4B;PRKACA
GO_Biological_Process_2021,Renal cell carcinoma,3/69,0.0543236103884726,0.5627636623456402,0,0,3.6523191094619674,10.638461708118632,RAP1B;TGFB2;ELOB
GO_Biological_Process_2021,Circadian rhythm,2/31,0.056276366234564,0.5627636623456402,0,0,5.529296327446033,15.91044299493512,CRY1;CSNK1D
GO_Biological_Process_2021,Thyroid hormone signaling pathway,4/121,0.0639438348684632,0.6074664312504009,0,0,2.751155947877259,7.564991510891257,HDAC2;RHEB;TSC2;PRKACA
GO_Biological_Process_2021,Thermogenesis,6/232,0.069641038413008,0.6292067945724362,0,0,2.1421048782271632,5.707426921682601,NDUFB9;KDM1A;RHEB;CREB3L2;TSC2;PRKACA
GO_Biological_Process_2021,Synaptic vesicle cycle,3/78,0.0728555235820715,0.6292067945724362,0,0,3.2125714285714286,8.414614222120594,ATP6V1G1;SYT1;ATP6V1E1
GO_Biological_Process_2021,Amyotrophic lateral sclerosis,8/364,0.0845273743275017,0.6745354444168926,0,0,1.8161048689138577,4.487013687937666,NDUFB9;SEC13;TUBA1A;PSMB1;NUP88;NUP153;WIPI1;SOD1
GO_Biological_Process_2021,Huntington disease,7/306,0.0874964559318565,0.6745354444168926,0,0,1.8897153721256192,4.603643313055605,NDUFB9;HDAC2;TUBA1A;CREB3L2;PSMB1;WIPI1;SOD1
GO_Biological_Process_2021,Pathogenic Escherichia coli infection,5/197,0.0990553874916857,0.6745354444168926,0,0,2.09619341563786,4.846558730140583,TUBA1A;SEC24A;WIPF1;CYTH1;WASF3
GO_Biological_Process_2021,Vasopressin-regulated water reabsorption,2/44,0.1032647133299988,0.6745354444168926,0,0,3.8153310104529616,8.662554749345768,CREB3L2;PRKACA
GO_Biological_Process_2021,Morphine addiction,3/91,0.1038265739625479,0.6745354444168926,0,0,2.736178107606679,6.197534610041286,PDE4B;PDE7B;PRKACA
GO_Biological_Process_2021,Cell adhesion molecules,4/148,0.1125106411293695,0.6745354444168926,0,0,2.23224043715847,4.8767923668121655,CADM1;NRXN3;NRCAM;MPZL1
GO_Biological_Process_2021,Phospholipase D signaling pathway,4/148,0.1125106411293695,0.6745354444168926,0,0,2.23224043715847,4.8767923668121655,RHEB;TSC2;CYTH1;AGPAT4
GO_Biological_Process_2021,Adrenergic signaling in cardiomyocytes,4/150,0.1166206433749853,0.6745354444168926,0,0,2.201437233325848,4.730512116594886,PPP1CC;CREB3L2;CREM;PRKACA
GO_Biological_Process_2021,Phagosome,4/152,0.1207955529070214,0.6745354444168926,0,0,2.171466548515729,4.589732881806325,ATP6V1G1;TUBA1A;CTSL;ATP6V1E1
GO_Biological_Process_2021,Choline metabolism in cancer,3/98,0.1223162795557279,0.6745354444168926,0,0,2.5336627282491944,5.323593111365672,RHEB;TSC2;WASF3
GO_Biological_Process_2021,Glycerophospholipid metabolism,3/98,0.1223162795557279,0.6745354444168926,0,0,2.5336627282491944,5.323593111365672,GNPAT;LPIN1;AGPAT4
GO_Biological_Process_2021,Cocaine addiction,2/49,0.1234253638731651,0.6745354444168926,0,0,3.408579830479156,7.131153422144283,CREB3L2;PRKACA
GO_Biological_Process_2021,Prion disease,6/273,0.1249199285480864,0.6745354444168926,0,0,1.8093602005757263,3.763618161103477,NDUFB9;TUBA1A;CREB3L2;PSMB1;PRKACA;SOD1
GO_Biological_Process_2021,AGE-RAGE signaling pathway in diabetic complications,3/100,0.1278067157842533,0.6745354444168926,0,0,2.4811697875026297,5.104352278516203,TGFB2;COL4A6;F3
GO_Biological_Process_2021,Amoebiasis,3/102,0.1333836460448836,0.6849430472575108,0,0,2.4307977736549167,4.896904699277051,TGFB2;COL4A6;PRKACA
GO_Biological_Process_2021,"Parathyroid hormone synthesis, secretion and action",3/106,0.1447842535750748,0.7239212678753741,0,0,2.3359223300970875,4.514194549164393,CREB3L2;PDE4B;PRKACA
GO_Biological_Process_2021,Insulin resistance,3/108,0.1506015584096407,0.7336998999444037,0,0,2.291195335276968,4.337502250140704,PPP1CC;PTPN1;CREB3L2
GO_Biological_Process_2021,Glycerolipid metabolism,2/61,0.1749405761761237,0.775538748432951,0,0,2.713655780625603,4.730740348341082,LPIN1;AGPAT4
GO_Biological_Process_2021,AMPK signaling pathway,3/120,0.1869438659604783,0.775538748432951,0,0,2.0549450549450547,3.4460337174096147,RHEB;CREB3L2;TSC2
GO_Biological_Process_2021,Cortisol synthesis and secretion,2/65,0.1928007989827288,0.775538748432951,0,0,2.54084397986837,4.182477565255648,CREB3L2;PRKACA
GO_Biological_Process_2021,Salmonella infection,5/249,0.1976667904521585,0.775538748432951,0,0,1.6450785940767725,2.666956246838845,TUBA1A;CSE1L;RHOJ;WASF3;CYTH1
GO_Biological_Process_2021,Platelet activation,3/124,0.1995310429939864,0.775538748432951,0,0,1.9866081969978076,3.20198618831615,RAP1B;PPP1CC;PRKACA
GO_Biological_Process_2021,Alcoholism,4/186,0.2003901131097984,0.775538748432951,0,0,1.7627454512700411,2.8335943577056666,PPP1CC;HDAC2;CREB3L2;PRKACA
GO_Biological_Process_2021,RNA transport,4/186,0.2003901131097984,0.775538748432951,0,0,1.7627454512700411,2.8335943577056666,SEC13;STRAP;NUP88;NUP153
GO_Biological_Process_2021,Endocytosis,5/252,0.2041746090442394,0.775538748432951,0,0,1.6248479698772096,2.581525510011995,WIPF1;SMAP1;EPN1;CYTH1;SNX6
GO_Biological_Process_2021,Epithelial cell signaling in Helicobacter pylori infection,2/70,0.2154314292172794,0.775538748432951,0,0,2.3534194165471067,3.6127638322800473,ATP6V1G1;ATP6V1E1
GO_Biological_Process_2021,Oocyte meiosis,3/129,0.2155376168630739,0.775538748432951,0,0,1.9072886297376093,2.926962949796096,PPP1CC;SPDYE3;PRKACA
GO_Biological_Process_2021,Relaxin signaling pathway,3/129,0.2155376168630739,0.775538748432951,0,0,1.9072886297376093,2.926962949796096,CREB3L2;COL4A6;PRKACA
GO_Biological_Process_2021,Adherens junction,2/71,0.2199882631164538,0.775538748432951,0,0,2.3191940615058324,3.511679776952338,PTPN1;WASF3
GO_Biological_Process_2021,FoxO signaling pathway,3/131,0.2220155679135725,0.775538748432951,0,0,1.877295918367347,2.825344950925451,TGFB2;HOMER2;KLF2
GO_Biological_Process_2021,Dopaminergic synapse,3/132,0.2252692330646427,0.775538748432951,0,0,1.8626483151400093,2.7762009464841912,PPP1CC;CREB3L2;PRKACA
GO_Biological_Process_2021,Oxidative phosphorylation,3/133,0.2285322151476056,0.775538748432951,0,0,1.8482260596546312,2.7281259980423243,NDUFB9;ATP6V1G1;ATP6V1E1
GO_Biological_Process_2021,Pantothenate and CoA biosynthesis,1/21,0.2306115424961228,0.775538748432951,0,0,3.994331983805668,5.859767376219536,PANK2
GO_Biological_Process_2021,Thyroid hormone synthesis,2/75,0.2382871981006776,0.775538748432951,0,0,2.191669450941085,3.143464631421043,CREB3L2;PRKACA
GO_Biological_Process_2021,Focal adhesion,4/201,0.239551964823574,0.775538748432951,0,0,1.627278022801032,2.32535574472232,VAV3;RAP1B;PPP1CC;COL4A6
GO_Biological_Process_2021,Histidine metabolism,1/22,0.2401619734909809,0.775538748432951,0,0,3.803932909196067,5.426088501828651,ASPA
GO_Biological_Process_2021,Chronic myeloid leukemia,2/76,0.2428755069890877,0.775538748432951,0,0,2.161942430235113,3.0595945125648902,HDAC2;TGFB2
GO_Biological_Process_2021,Viral carcinogenesis,4/203,0.2449069731893529,0.775538748432951,0,0,1.610758711590741,2.2661391290809454,HDAC2;DDX3X;CREB3L2;PRKACA
GO_Biological_Process_2021,Ubiquitin mediated proteolysis,3/140,0.2516045794785809,0.7836863950972193,0,0,1.753165499776553,2.419187029798372,ELOB;MID1;PIAS2
GO_Biological_Process_2021,Vitamin digestion and absorption,1/24,0.2589100565616392,0.7934340443017974,0,0,3.4728040837880654,4.692711774024783,BTD
GO_Biological_Process_2021,Peroxisome,2/82,0.2704573604606072,0.8105691911238548,0,0,1.9991869918699188,2.61421852823604,GNPAT;SOD1
GO_Biological_Process_2021,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/26,0.2771973722675881,0.8105691911238548,0,0,3.1946558704453443,4.098824917602273,PIGL
GO_Biological_Process_2021,Gastric cancer,3/149,0.2817267386808171,0.8105691911238548,0,0,1.64433883142298,2.083077519358604,TGFB2;CSNK1A1;RARB
GO_Biological_Process_2021,Regulation of actin cytoskeleton,4/218,0.2858205809714036,0.8105691911238548,0,0,1.4967059905009958,1.874461118559507,VAV3;PPP1CC;TMSB4X;SSH1
GO_Biological_Process_2021,Insulin secretion,2/86,0.2888408408492338,0.8105691911238548,0,0,1.9036004645760745,2.3640423289557697,CREB3L2;PRKACA
GO_Biological_Process_2021,Cushing syndrome,3/155,0.3019885943458745,0.8105691911238548,0,0,1.5789473684210529,1.8905779411375288,RAP1B;CREB3L2;PRKACA
GO_Biological_Process_2021,Human cytomegalovirus infection,4/225,0.3052577148778774,0.8105691911238548,0,0,1.4487797641124545,1.7191204633484187,RHEB;CREB3L2;TSC2;PRKACA
GO_Biological_Process_2021,Alzheimer disease,6/369,0.3088621775894792,0.8105691911238548,0,0,1.3242947886073355,1.555861145915869,NDUFB9;TUBA1A;CSF1;CSNK1A1;PSMB1;WIPI1
GO_Biological_Process_2021,Small cell lung cancer,2/92,0.3163034742276975,0.8105691911238548,0,0,1.7761517615176152,2.0444451062017293,COL4A6;RARB
GO_Biological_Process_2021,Hepatitis B,3/162,0.3257105495225401,0.8105691911238548,0,0,1.5088948787061995,1.6925970615611636,TGFB2;DDX3X;CREB3L2
GO_Biological_Process_2021,Dilated cardiomyopathy,2/96,0.3344824880190117,0.8105691911238548,0,0,1.7002248745891717,1.8620365570110071,TGFB2;PRKACA
GO_Biological_Process_2021,SNARE interactions in vesicular transport,1/33,0.3377348165754323,0.8105691911238548,0,0,2.4949392712550607,2.7082422524503027,STX6
GO_Biological_Process_2021,Fc gamma R-mediated phagocytosis,2/97,0.3390062347996205,0.8105691911238548,0,0,1.682242190842961,1.819743250755633,VAV3;WASF3
GO_Biological_Process_2021,Prostate cancer,2/97,0.3390062347996205,0.8105691911238548,0,0,1.682242190842961,1.819743250755633,CREB3L2;ETV5
GO_Biological_Process_2021,Wnt signaling pathway,3/166,0.3392716415295591,0.8105691911238548,0,0,1.4715662952297484,1.5906957527296597,CSNK1A1;PRKACA;NKD1
GO_Biological_Process_2021,Aldosterone synthesis and secretion,2/98,0.3435206082300405,0.8105691911238548,0,0,1.6646341463414631,1.778675192538267,CREB3L2;PRKACA
GO_Biological_Process_2021,mRNA surveillance pathway,2/98,0.3435206082300405,0.8105691911238548,0,0,1.6646341463414631,1.778675192538267,PPP1CC;RNMT
GO_Biological_Process_2021,Inflammatory mediator regulation of TRP channels,2/98,0.3435206082300405,0.8105691911238548,0,0,1.6646341463414631,1.778675192538267,PPP1CC;PRKACA
GO_Biological_Process_2021,Progesterone-mediated oocyte maturation,2/100,0.3525193991192274,0.8105691911238548,0,0,1.630496100879376,1.700036148605194,SPDYE3;PRKACA
GO_Biological_Process_2021,Melanogenesis,2/101,0.3570029302794641,0.8105691911238548,0,0,1.6139443212613944,1.6623808709917889,CREB3L2;PRKACA
GO_Biological_Process_2021,"Alanine, aspartate and glutamate metabolism",1/37,0.3700318458460745,0.8105691911238548,0,0,2.2172739541160595,2.204338837272295,ASPA
GO_Biological_Process_2021,Parkinson disease,4/249,0.3726083366909756,0.8105691911238548,0,0,1.3052525928404148,1.2885811845193078,NDUFB9;TUBA1A;PSMB1;PRKACA
GO_Biological_Process_2021,Pathways of neurodegeneration,7/475,0.3756741402352047,0.8105691911238548,0,0,1.196829449941483,1.1717357179499075,NDUFB9;TUBA1A;CSF1;CSNK1A1;PSMB1;WIPI1;SOD1
GO_Biological_Process_2021,Glucagon signaling pathway,2/107,0.3836560200020188,0.8105691911238548,0,0,1.5212543554006968,1.4573752254672503,CREB3L2;PRKACA
GO_Biological_Process_2021,HIF-1 signaling pathway,2/109,0.392436733665228,0.8105691911238548,0,0,1.492667730415622,1.3962114563940011,ELOB;ENO1
GO_Biological_Process_2021,TNF signaling pathway,2/112,0.4055010723189627,0.8105691911238548,0,0,1.4517368810051736,1.3103838174012878,CSF1;CREB3L2
GO_Biological_Process_2021,Serotonergic synapse,2/113,0.4098261250182639,0.8105691911238548,0,0,1.4385849263898045,1.2832498269500416,KCND2;PRKACA
GO_Biological_Process_2021,Cholinergic synapse,2/113,0.4098261250182639,0.8105691911238548,0,0,1.4385849263898045,1.2832498269500416,CREB3L2;PRKACA
GO_Biological_Process_2021,Glutamatergic synapse,2/114,0.4141358161225283,0.8105691911238548,0,0,1.4256678281068524,1.2568135848966142,HOMER2;PRKACA
GO_Biological_Process_2021,Leukocyte transendothelial migration,2/114,0.4141358161225283,0.8105691911238548,0,0,1.4256678281068524,1.2568135848966142,RAP1B;VAV3
GO_Biological_Process_2021,Chemokine signaling pathway,3/192,0.4263557020965486,0.8105691911238548,0,0,1.267444120505345,1.0804724111056605,RAP1B;VAV3;PRKACA
GO_Biological_Process_2021,Basal transcription factors,1/45,0.4299948104368467,0.8105691911238548,0,0,1.813397129186603,1.5304747881629384,TAF7
GO_Biological_Process_2021,"Growth hormone synthesis, secretion and action",2/119,0.4354442154540195,0.8105691911238548,0,0,1.364394413174901,1.1343419391819956,CREB3L2;PRKACA
GO_Biological_Process_2021,Proteasome,1/46,0.4370787996748392,0.8105691911238548,0,0,1.7730094466936572,1.467416695340528,PSMB1
GO_Biological_Process_2021,PI3K-Akt signaling pathway,5/354,0.4479343073956963,0.8105691911238548,0,0,1.143950381454361,0.9187164952452154,CSF1;RHEB;CREB3L2;COL4A6;TSC2
GO_Biological_Process_2021,Cell cycle,2/124,0.4563297438393979,0.8105691911238548,0,0,1.3081434093029456,1.026290317987085,TGFB2;HDAC2
GO_Biological_Process_2021,Diabetic cardiomyopathy,3/203,0.4620769443475302,0.8105691911238548,0,0,1.197061224489796,0.9241598218730674,PPP1CC;NDUFB9;TGFB2
GO_Biological_Process_2021,Cysteine and methionine metabolism,1/50,0.4645486115664432,0.8105691911238548,0,0,1.627943485086342,1.248126480940435,APIP
GO_Biological_Process_2021,Malaria,1/50,0.4645486115664432,0.8105691911238548,0,0,1.627943485086342,1.248126480940435,TGFB2
GO_Biological_Process_2021,N-Glycan biosynthesis,1/50,0.4645486115664432,0.8105691911238548,0,0,1.627943485086342,1.248126480940435,DPM1
GO_Biological_Process_2021,Osteoclast differentiation,2/127,0.4686466884593664,0.8105691911238548,0,0,1.2765528455284554,0.9675072191616868,TGFB2;CSF1
GO_Biological_Process_2021,Ovarian steroidogenesis,1/51,0.4712048349934808,0.8105691911238548,0,0,1.5953036437246964,1.2004059856340397,PRKACA
GO_Biological_Process_2021,Lysosome,2/128,0.4727154588344616,0.8105691911238548,0,0,1.2663569492837785,0.948832682683373,LAPTM4A;CTSL
GO_Biological_Process_2021,Purine metabolism,2/129,0.4767655018208274,0.8105691911238548,0,0,1.2563216183342936,0.9305957648977172,PDE4B;PDE7B
GO_Biological_Process_2021,Endocrine and other factor-regulated calcium reabsorption,1/53,0.4842710544938633,0.8105691911238548,0,0,1.533790096543133,1.1121673023849068,PRKACA
GO_Biological_Process_2021,Glycosaminoglycan biosynthesis,1/53,0.4842710544938633,0.8105691911238548,0,0,1.533790096543133,1.1121673023849068,CHST11
GO_Biological_Process_2021,Rap1 signaling pathway,3/210,0.4843062979350583,0.8105691911238548,0,0,1.1561668145519075,0.8382645574697837,VAV3;RAP1B;CSF1
GO_Biological_Process_2021,Pathways in cancer,7/531,0.4885015190933353,0.8105691911238548,0,0,1.0658198980076652,0.7635669084943404,TGFB2;HDAC2;SUFU;COL4A6;RARB;ELOB;PRKACA
GO_Biological_Process_2021,Vascular smooth muscle contraction,2/133,0.4927752551296517,0.8105691911238548,0,0,1.2177124061316948,0.8617776036702286,PPP1CC;PRKACA
GO_Biological_Process_2021,MAPK signaling pathway,4/294,0.4962776782659354,0.8105691911238548,0,0,1.1001695873374788,0.7708004572872379,RAP1B;TGFB2;CSF1;PRKACA
GO_Biological_Process_2021,Regulation of lipolysis in adipocytes,1/55,0.4970156841561089,0.8105691911238548,0,0,1.4768331084120558,1.0325037890535649,PRKACA
GO_Biological_Process_2021,Apelin signaling pathway,2/137,0.5084735808446875,0.8105691911238548,0,0,1.1813911472448058,0.7990244748403167,PRKACA;KLF2
GO_Biological_Process_2021,Yersinia infection,2/137,0.5084735808446875,0.8105691911238548,0,0,1.1813911472448058,0.7990244748403167,VAV3;WIPF1
GO_Biological_Process_2021,Estrogen signaling pathway,2/137,0.5084735808446875,0.8105691911238548,0,0,1.1813911472448058,0.7990244748403167,CREB3L2;PRKACA
GO_Biological_Process_2021,Human T-cell leukemia virus 1 infection,3/219,0.5122282757745322,0.8105691911238548,0,0,1.107482993197279,0.7408894018729469,TGFB2;CREB3L2;PRKACA
GO_Biological_Process_2021,Fluid shear stress and atherosclerosis,2/139,0.5162034880643791,0.8105691911238548,0,0,1.1640258738353806,0.7697170381701147,CTSL;KLF2
GO_Biological_Process_2021,Notch signaling pathway,1/59,0.5215715167046887,0.8105691911238548,0,0,1.374703336590814,0.8948066055858285,HDAC2
GO_Biological_Process_2021,Apoptosis,2/142,0.5276469326428614,0.8105691911238548,0,0,1.1389082462253195,0.7281358254654187,TUBA1A;CTSL
GO_Biological_Process_2021,Spinocerebellar ataxia,2/143,0.5314206747947899,0.8105691911238548,0,0,1.1307732226258431,0.7148763467359672,PSMB1;WIPI1
GO_Biological_Process_2021,Steroid hormone biosynthesis,1/61,0.5333979143130759,0.8105691911238548,0,0,1.3287449392712551,0.8350996878864658,CYP3A5
GO_Biological_Process_2021,Basal cell carcinoma,1/63,0.5449331209077333,0.8105691911238548,0,0,1.2857515998432807,0.780569774833543,SUFU
GO_Biological_Process_2021,Lysine degradation,1/63,0.5449331209077333,0.8105691911238548,0,0,1.2857515998432807,0.780569774833543,CAMKMT
GO_Biological_Process_2021,Retrograde endocannabinoid signaling,2/148,0.5499804159421988,0.8105691911238548,0,0,1.091769684820136,0.6527391896365751,NDUFB9;PRKACA
GO_Biological_Process_2021,Ras signaling pathway,3/232,0.5511067348352893,0.8105691911238548,0,0,1.0439176543980038,0.6219940919472756,RAP1B;CSF1;PRKACA
GO_Biological_Process_2021,Inflammatory bowel disease,1/65,0.5561842778718857,0.8105691911238548,0,0,1.2454453441295548,0.7306474913847649,TGFB2
GO_Biological_Process_2021,Glycolysis / Gluconeogenesis,1/67,0.5671583521764124,0.8105691911238548,0,0,1.207581891792418,0.684839897921046,ENO1
GO_Biological_Process_2021,Chemical carcinogenesis,3/239,0.5712729660658226,0.8105691911238548,0,0,1.012590799031477,0.5669375733835448,CREB3L2;PRKACA;CYP3A5
GO_Biological_Process_2021,Oxytocin signaling pathway,2/154,0.5715647111725098,0.8105691911238548,0,0,1.0483525887890457,0.5864249254643471,PPP1CC;PRKACA
GO_Biological_Process_2021,Fc epsilon RI signaling pathway,1/68,0.5725436138609863,0.8105691911238548,0,0,1.1894978548552784,0.6633429449386279,VAV3
GO_Biological_Process_2021,Retinol metabolism,1/68,0.5725436138609863,0.8105691911238548,0,0,1.1894978548552784,0.6633429449386279,CYP3A5
GO_Biological_Process_2021,Renin secretion,1/69,0.5778621405472457,0.8105691911238548,0,0,1.171945701357466,0.6427184028497713,PRKACA
GO_Biological_Process_2021,RIG-I-like receptor signaling pathway,1/70,0.5831147560375989,0.8105691911238548,0,0,1.1549023059320542,0.6229211291208464,DDX3X
GO_Biological_Process_2021,Non-small cell lung cancer,1/72,0.5934254973990518,0.8105691911238548,0,0,1.122255802018589,0.5856420120344802,RARB
GO_Biological_Process_2021,p53 signaling pathway,1/73,0.5984852205205964,0.8105691911238548,0,0,1.106612685560054,0.5680834382752458,TSC2
GO_Biological_Process_2021,JAK-STAT signaling pathway,2/162,0.599164402629931,0.8105691911238548,0,0,0.9955284552845528,0.5099288453943894,FHL1;PIAS2
GO_Biological_Process_2021,Gastric acid secretion,1/76,0.6132911780973639,0.8105691911238548,0,0,1.0621862348178135,0.519319261800102,PRKACA
GO_Biological_Process_2021,Metabolism of xenobiotics by cytochrome P450,1/76,0.6132911780973639,0.8105691911238548,0,0,1.0621862348178135,0.519319261800102,CYP3A5
GO_Biological_Process_2021,Pancreatic cancer,1/76,0.6132911780973639,0.8105691911238548,0,0,1.0621862348178135,0.519319261800102,TGFB2
GO_Biological_Process_2021,cGMP-PKG signaling pathway,2/167,0.6157270512109019,0.8105691911238548,0,0,0.9651145602365114,0.4680337655578666,PPP1CC;CREB3L2
GO_Biological_Process_2021,Arrhythmogenic right ventricular cardiomyopathy,1/77,0.6181046426000314,0.8105691911238548,0,0,1.0481568293202643,0.5042656419990001,GJA1
GO_Biological_Process_2021,Leishmaniasis,1/77,0.6181046426000314,0.8105691911238548,0,0,1.0481568293202643,0.5042656419990001,TGFB2
GO_Biological_Process_2021,Hepatocellular carcinoma,2/168,0.6189762066186443,0.8105691911238548,0,0,0.959251640709178,0.4601419283322387,TGFB2;CSNK1A1
GO_Biological_Process_2021,Tight junction,2/169,0.6222042735764058,0.8105691911238548,0,0,0.9534589357869626,0.452403704209699,TUBA1A;PRKACA
GO_Biological_Process_2021,Antigen processing and presentation,1/78,0.62285843107412,0.8105691911238548,0,0,1.034491823965508,0.489765695438295,CTSL
GO_Biological_Process_2021,RNA degradation,1/79,0.6275532803386498,0.8111232875125406,0,0,1.021177203363438,0.4757937272095353,ENO1
GO_Biological_Process_2021,B cell receptor signaling pathway,1/81,0.6367690634774649,0.8174737977075562,0,0,0.9955465587044534,0.4493381740224973,VAV3
GO_Biological_Process_2021,Complement and coagulation cascades,1/85,0.6545247899853248,0.8261744813829883,0,0,0.9479467900520532,0.4017832827737792,F3
GO_Biological_Process_2021,Taste transduction,1/86,0.6588269501475342,0.8261744813829883,0,0,0.9367468444867826,0.3908991876735517,PRKACA
GO_Biological_Process_2021,Colorectal cancer,1/86,0.6588269501475342,0.8261744813829883,0,0,0.9367468444867826,0.3908991876735517,TGFB2
GO_Biological_Process_2021,ECM-receptor interaction,1/88,0.6672718461286911,0.8261744813829883,0,0,0.9151193633952256,0.3702186312665764,COL4A6
GO_Biological_Process_2021,GABAergic synapse,1/89,0.6714158921781626,0.8261744813829883,0,0,0.9046742730953258,0.3603919459844025,PRKACA
GO_Biological_Process_2021,Bile secretion,1/90,0.6755085304079126,0.8261744813829883,0,0,0.8944639039257608,0.3508887917128628,PRKACA
GO_Biological_Process_2021,Hypertrophic cardiomyopathy,1/90,0.6755085304079126,0.8261744813829883,0,0,0.8944639039257608,0.3508887917128628,TGFB2
GO_Biological_Process_2021,Salivary secretion,1/93,0.6874843112142106,0.8261744813829883,0,0,0.8651645837000528,0.3241912455272258,PRKACA
GO_Biological_Process_2021,GnRH signaling pathway,1/93,0.6874843112142106,0.8261744813829883,0,0,0.8651645837000528,0.3241912455272258,PRKACA
GO_Biological_Process_2021,Transcriptional misregulation in cancer,2/192,0.6907089360614661,0.8261744813829883,0,0,0.837056054771074,0.3097415148675133,HDAC2;ETV5
GO_Biological_Process_2021,TGF-beta signaling pathway,1/94,0.6913775923152377,0.8261744813829883,0,0,0.8558182055635366,0.3158561072392628,TGFB2
GO_Biological_Process_2021,Circadian entrainment,1/97,0.7027699615491018,0.8279785045105601,0,0,0.8289473684210527,0.2923910115200888,PRKACA
GO_Biological_Process_2021,Phosphatidylinositol signaling system,1/97,0.7027699615491018,0.8279785045105601,0,0,0.8289473684210527,0.2923910115200888,PIP4P2
GO_Biological_Process_2021,Hematopoietic cell lineage,1/99,0.7101311917591902,0.8279785045105601,0,0,0.8119474510451954,0.2779341179001433,CSF1
GO_Biological_Process_2021,Viral protein interaction with cytokine and cytokine receptor,1/100,0.7137434279293841,0.8279785045105601,0,0,0.8037050668629616,0.2710348467798397,CSF1
GO_Biological_Process_2021,Chagas disease,1/102,0.7208339484602605,0.8279785045105601,0,0,0.7877099450835772,0.2578540742309804,TGFB2
GO_Biological_Process_2021,Pancreatic secretion,1/102,0.7208339484602605,0.8279785045105601,0,0,0.7877099450835772,0.2578540742309804,RAP1B
GO_Biological_Process_2021,Protein digestion and absorption,1/103,0.7243133345278556,0.8279785045105601,0,0,0.7799476065729936,0.2515574357089533,COL4A6
GO_Biological_Process_2021,T cell receptor signaling pathway,1/104,0.7277495276487554,0.8279785045105601,0,0,0.7723359930820329,0.2454471007048649,VAV3
GO_Biological_Process_2021,Drug metabolism,1/108,0.7410729536853601,0.834450647251823,0,0,0.7433122706118279,0.222738134524688,CYP3A5
GO_Biological_Process_2021,MicroRNAs in cancer,3/310,0.7422218915029374,0.834450647251823,0,0,0.775576680183474,0.231204864829771,TGFB2;HDAC2;PDCD4
GO_Biological_Process_2021,Lipid and atherosclerosis,2/215,0.7486873711272402,0.8367682383186802,0,0,0.7457918241154242,0.2158573449734628,VAV3;RAP1B
GO_Biological_Process_2021,Toxoplasmosis,1/112,0.7537468521732521,0.8374965024147246,0,0,0.7163803479592953,0.2025197982105794,TGFB2
GO_Biological_Process_2021,Sphingolipid signaling pathway,1/119,0.774457261503516,0.8505599981830523,0,0,0.6736430384958485,0.1721783122259357,S1PR3
GO_Biological_Process_2021,Neurotrophin signaling pathway,1/119,0.774457261503516,0.8505599981830523,0,0,0.6736430384958485,0.1721783122259357,RAP1B
GO_Biological_Process_2021,Natural killer cell mediated cytotoxicity,1/131,0.8060041599034836,0.8801194849520799,0,0,0.6110868888196823,0.1317908943162487,VAV3
GO_Biological_Process_2021,Shigellosis,2/246,0.8119161877364753,0.8815090038281732,0,0,0.6500066640010662,0.1354341932926676,WIPI1;CYTH1
GO_Biological_Process_2021,Breast cancer,1/147,0.8413346410088585,0.9082589874527448,0,0,0.543674782319339,0.0939284031078652,CSNK1A1
GO_Biological_Process_2021,Spliceosome,1/150,0.8472069571509647,0.9094311969417136,0,0,0.5326467950982257,0.0883183103981354,SRSF10
GO_Biological_Process_2021,Non-alcoholic fatty liver disease,1/155,0.8565169834057262,0.9142597013881348,0,0,0.5152216204847784,0.0797981081050118,NDUFB9
GO_Biological_Process_2021,Ribosome,1/158,0.8618294967984432,0.9147910859871744,0,0,0.5052992599087135,0.0751369021459262,RPS21
GO_Biological_Process_2021,Cytokine-cytokine receptor interaction,2/295,0.8832971517590726,0.9323692157456878,0,0,0.5399428397014345,0.0670034560542905,TGFB2;CSF1
GO_Biological_Process_2021,Tuberculosis,1/180,0.8952433486123721,0.9373143940253728,0,0,0.4426978490489223,0.0489888110663031,TGFB2
GO_Biological_Process_2021,Axon guidance,1/182,0.8978485248032517,0.9373143940253728,0,0,0.437761424385443,0.0471705031670756,SSH1
GO_Biological_Process_2021,Neutrophil extracellular trap formation,1/189,0.9064687871176488,0.9411424565702364,0,0,0.4213110517701783,0.0413721898621771,HDAC2
GO_Biological_Process_2021,Epstein-Barr virus infection,1/202,0.92060114566156,0.9500066573210196,0,0,0.3938002296211251,0.0325784641476326,HDAC2
GO_Biological_Process_2021,Neuroactive ligand-receptor interaction,2/341,0.9267087727537664,0.9500066573210196,0,0,0.4655730628102741,0.035437523760262,GLRB;S1PR3
GO_Biological_Process_2021,Human immunodeficiency virus 1 infection,1/212,0.930006517166893,0.9500066573210196,0,0,0.3749448356582305,0.0272073790044669,ELOB
GO_Biological_Process_2021,Coronavirus disease,1/232,0.945617207652332,0.9558731438130113,0,0,0.3421315526578684,0.0191311188209307,RPS21
GO_Biological_Process_2021,Herpes simplex virus 1 infection,3/498,0.9484703032469534,0.9558731438130113,0,0,0.4763636363636364,0.0252019225626793,PPP1CC;RHEB;TSC2
GO_Biological_Process_2021,Calcium signaling pathway,1/240,0.9508422325297848,0.9558731438130113,0,0,0.3305439330543933,0.0166617698778794,PRKACA
GO_Biological_Process_2021,Olfactory transduction,1/440,0.996116400993492,0.996116400993492,0,0,0.1781099849676758,0.0006930544061404277,PRKACA
